Found: 22
Select item for more details and to access through your institution.
Recombination-Associated Sequence Homogenization of Neighboring Alu Elements: Signature of Nonallelic Gene Conversion.
- Published in:
- Molecular Biology & Evolution, 2010, v. 27, n. 10, p. 2300, doi. 10.1093/molbev/msq116
- By:
- Publication type:
- Article
The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant.
- Published in:
- Case Reports in Obstetrics & Gynecology, 2022, p. 1, doi. 10.1155/2022/9412201
- By:
- Publication type:
- Article
Treatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case Report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in Metastatic Microsatellite Stable Colorectal Cancer with a High Tumor Mutation Burden.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 2, p. 849, doi. 10.1159/000516190
- By:
- Publication type:
- Article
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11529, doi. 10.3390/ijms231911529
- By:
- Publication type:
- Article
Early circulating tumor DNA dynamics as a pan‐tumor biomarker for long‐term clinical outcome in patients treated with durvalumab and tremelimumab.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 2, p. 298, doi. 10.1002/1878-0261.13349
- By:
- Publication type:
- Article
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 220, doi. 10.1093/oncolo/oyac249
- By:
- Publication type:
- Article
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1253629
- By:
- Publication type:
- Article
Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitoring assay.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1221718
- By:
- Publication type:
- Article
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25432-7
- By:
- Publication type:
- Article
Morphological Changes and Immunohistochemical Expression of RAGE and its Ligands in the Sciatic Nerve of Hyperglycemic Pig (Sus Scrofa).
- Published in:
- Biochemistry Insights, 2010, n. 3, p. 47, doi. 10.4137/BCI.S5340
- By:
- Publication type:
- Article
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in earlystage lung cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 10, p. 1758, doi. 10.1002/cncr.35263
- By:
- Publication type:
- Article
Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 11, p. 1723, doi. 10.1002/cncr.34716
- By:
- Publication type:
- Article
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00239-3
- By:
- Publication type:
- Article
Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma.
- Published in:
- Experimental Hematology & Oncology, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0113-x
- By:
- Publication type:
- Article
Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.786451
- By:
- Publication type:
- Article
Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 157, doi. 10.3390/cancers15010157
- By:
- Publication type:
- Article
Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Tumor-Informed Assessment of Molecular Residual Disease and Its Incorporation Into Practice for Patients With Early- and Advanced-Stage Colorectal Cancer (CRC-MRD Consortia)... [including commentary by Tanios S. Bekaii-Saab].
- Published in:
- Oncology (08909091), 2020, v. 34, n. 11, p. 474
- By:
- Publication type:
- Article
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy.
- Published in:
- Cancer Science, 2022, v. 113, n. 4, p. 1531, doi. 10.1111/cas.15226
- By:
- Publication type:
- Article
CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 7, p. 2915, doi. 10.1111/cas.14926
- By:
- Publication type:
- Article